Evidence map›Paper›PMID 29017486›Full record

ReviewBMC medical ethics2017

Limits to human enhancement: nature, disease, therapy or betterment?

Bjørn Hofmann

Abstract readReview
In one paragraph

Review in BMC medical ethics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Clashing Perspectives? Two Approaches to the Desirability of Biological Aging.Health care analysis : HCA : journal of health philosophy and policy · 2026
    Article
  2. Article
  3. Article
  4. Well-being and enhancement: reassessing the welfarist account.Medicine, health care, and philosophy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The role of philosophy and ethics at the edges of medicine.Philosophy, ethics, and humanities in medicine : PEHM · 2021
    Article
  10. Review
  11. Expanding disease and undermining the ethos of medicine.European journal of epidemiology · 2019
    Article
  12. Article
  13. Article
  14. The gene-editing of super-ego.Medicine, health care, and philosophy · 2018
    Article
  15. How medical technologies shape the experience of illness.Life sciences, society and policy · 2018
    Article
  16. Young Blood Rejuvenates Old Bodies: A Call for Reflection when Moving from Mice to Men.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2018
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bjørn HofmannNorwegian University of Science and Technology (NTNU), Gjøvik, Norway. b.m.hofmann@medisin.uio.no.ORCID http://orcid.org/0000-0001-6709-4265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew technologies facilitate the enhancement of a wide range of human dispositions, capacities, or abilities. While it is argued that we need to set limits to human enhancement, it is unclear where we should find resources to set such limits. DISCUSSION: Traditional routes for setting limits, such as referring to nature, the therapy-enhancement distinction, and the health-disease distinction, turn out to have some shortcomings. However, upon closer scrutiny the concept of enhancement is based on vague conceptions of what is to be enhanced. Explaining why it is better to become older, stronger, and more intelligent presupposes a clear conception of goodness, which is seldom provided. In particular, the qualitative better is frequently confused with the quantitative more. We may therefore not need "external" measures for setting its limits - they are available in the concept of enhancement itself. While there may be shortcomings in traditional sources of limit setting to human enhancement, such as nature, therapy, and disease, such approaches may not be necessary. The specification-of-betterment problem inherent in the conception of human enhancement itself provides means to restrict its unwarranted proliferation. We only need to demand clear, sustainable, obtainable goals for enhancement that are based on evidence, and not on lofty speculations, hypes, analogies, or weak associations. Human enhancements that specify what will become better, and provide adequate evidence, are good and should be pursued. Others should not be accepted.

Indexed as

Ethics, MedicalBiomedical EnhancementHuman CharacteristicsHumansRisk AssessmentDiseaseEnhancementLimitsNaturalnessNatureTherapy

Identifiers

PMID29017486
PMCPMC5635529

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.